However, SARS‐CoV2‐infected stem cell‐derived T2AE cells had increased rather than decreased CRTAC1 message compared to uninfected controls (Huang et al., 2020), and RNA‐Seq data in reference (Delorey et al., 2021) analyzed by the pseudobulk method revealed only a 1.3‐fold decrease in CRTAC1 mRNA in T2AE cells in lungs of deceased COVID‐19 patients compared to controls dying with healthy lungs (Supplementary spreadsheet 3). This evidence concerns the gene CRTAC1 and COVID-19.